StonvexLoading…
StonvexStonvexStonvexCore line items from CRSP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.46M | $3.51M | $2.65M | $1.76M |
Operating Income | $-130.25M | $-664.57M | $-509.81M | $-377.75M |
Net Income | $-122.93M | $-581.60M | $-450.99M | $-208.55M |
EPS (Diluted) | $-1.28 | $-6.47 | $-5.12 | $-3.98 |
Total Assets | $2.73B | $2.27B | $2.25B | $2.03B |
Total Liabilities | $911.26M | $343.43M | $329.33M | $318.59M |
Cash & Equivalents | $423.31M | $347.56M | $286.50M | $193.62M |
Free Cash Flow OCF − CapEx | $-109.40M | $-345.93M | $-252.86M | $-168.15M |
Shares Outstanding | 96.39M | 95.89M | 93.87M | 88.38M |